GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4

Journal of Biological Chemistry

Volumn 289, Issue 36, 2014, Pages 24759-24770

  Huo, Xiaodong ^a   Liu, Shu ^a   Shao, Ting ^a   Hua, Hui ^a   Kong, Qingbin ^a   Wang, Jiao ^b   Luo, Ting ^a   Jiang, Yangfu ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL PROLIFERATION; ENZYMES; INSULIN; TRANSCRIPTION; TRANSCRIPTION FACTORS; TUMORS;

CELLULAR PROLIFERATIONS; CONSTITUTIVELY ACTIVES; FORKHEAD TRANSCRIPTIONS; GLYCOGEN SYNTHASE KINASE-3; INSULIN-LIKE GROWTH FACTOR RECEPTORS; SIGNALING PATHWAYS; TRANSACTIVATION ACTIVITY; TUBEROUS SCLEROSIS;

CELL SIGNALING;

GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO4; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; FOXO3 PROTEIN, HUMAN; FOXO4 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3 BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BINDING;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; TRANSACTIVATION; BIOLOGICAL MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MODELS, GENETIC; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84906987331     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.580738     Document Type: Article

References (54)

1. Cohen, P., and Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776
2. Frame, S., and Cohen, P. (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359, 1-16
3. Luo, J. (2009) Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy. Cancer Lett. 273, 194-200
4. Buller, C. L., Loberg, R. D., Fan, M. H., Zhu, Q., Park, J. L., Vesely, E., Inoki, K., Guan, K. L., and Brosius, F. C., 3rd (2008) A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am. J. Physiol. Cell Physiol. 295, C836-C843
5. Jope, R. S., Yuskaitis, C. J., and Beurel, E. (2007) Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 32, 577-595
6. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789
7. Frame, S., Cohen, P., and Biondi, R. M. (2001) A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7, 1321-1327
8. Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B., and Rincon, M. (2008) Phosphorylation by p38 MAPK as an alternative pathway for GSK3β inactivation. Science 320, 667-670
9. Doble, B. W., and Woodgett, J. R. (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186
10. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., Zhang, Z., Lin, X., and He, X. (2002) Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847
11. Han, S. I., Aramata, S., Yasuda, K., and Kataoka, K. (2007) MafA stability in pancreatic beta cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3. Mol. Cell. Biol. 27, 6593-6605
12. Rocques, N., Abou Zeid, N., Sii-Felice, K., Lecoin, L., Felder-Schmittbuhl, M. P., Eychène, A., and Pouponnot, C. (2007) GSK-3-mediated phosphorylation enhances Maf-transforming activity. Mol. Cell 28, 584-597
13. Wu, R. C., Feng, Q., Lonard, D. M., and O'Malley, B. W. (2007) SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell 129, 1125-1140
14. Viatour, P., Dejardin, E., Warnier, M., Lair, F., Claudio, E., Bureau, F., Marine, J. C., Merville, M. P., Maurer, U., Green, D., Piette, J., Siebenlist, U., Bours, V., and Chariot, A. (2004) GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Mol. Cell 16, 35-45
15. Ougolkov, A. V., Fernandez-Zapico, M. E., Savoy, D. N., Urrutia, R. A., and Billadeau, D. D. (2005) Glycogen synthase kinase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res. 65, 2076-2081
16. Cao, Q., Lu, X., and Feng, Y. J. (2006) Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells. Cell Res. 16, 671-677
17. Abrahamsson, A. E., Geron, I., Gotlib, J., Dao, K. H., Barroga, C. F., Newton, I. G., Giles, F. J., Durocher, J., Creusot, R. S., Karimi, M., Jones, C., Zehnder, J. L., Keating, A., Negrin, R. S., Weissman, I. L., and Jamieson, C. H. (2009) Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation. Proc. Natl. Acad. Sci. U.S.A. 106, 3925-3929
18. Ding, Q., He, X., Xia, W., Hsu, J. M., Chen, C. T., Li, L. Y., Lee, D. F., Yang, J. Y., Xie, X., Liu, J. C., and Hung, M. C. (2007) Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3β activity and associates with poor prognosis in human breast cancer. Cancer Res. 67, 4564-4571
19. Farago, M., Dominguez, I., Landesman-Bollag, E., Xu, X., Rosner, A., Cardiff, R. D., and Seldin, D. C. (2005) Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis. Cancer Res. 65, 5792-5801
20. Kang, T., Wei, Y., Honaker, Y., Yamaguchi, H., Appella, E., Hung, M. C., and Piwnica-Worms, H. (2008) GSK-3β targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3β inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 13, 36-47
21. Woodgett, J. R. (2012) Can a two-faced kinase be exploited for osteosarcoma? J. Natl. Cancer Inst. 104, 722-723
22. Huang, H., and Tindall, D. J. (2007) Dynamic FoxO transcription factors. J. Cell Sci. 120, 2479-2487
23. Kloet, D. E., and Burgering, B. M. (2011) The PKB/FOXO switch in aging and cancer. Biochim. Biophys. Acta 1813, 1926-1937
24. Martínez-Gac, L., Marqués, M., García, Z., Campanero, M. R., and Carrera, A. C. (2004) Control of cyclin G2 mRNA expression by Forkhead transcription factors: Novel mechanism for cell cycle control by phosphoinositide 3-kinase and Forkhead. Mol. Cell. Biol. 24, 2181-2189
25. Svendsen, A. M., Winge, S. B., Zimmermann, M., Lindvig, A. B., Warzecha, C. B., Sajid, W., Horne, M. C., and De Meyts, P. (2014) Down-regulation of cyclin G2 by insulin, IGF-I (insulin-like growth factor 1) and X10 (AspB10 insulin): role in mitogenesis. Biochem. J. 457, 69-77
26. Paik, J. H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J. W., Carrasco, D. R., Jiang, S., Gilliland, D. G., Chin, L., Wong, W. H., Castrillon, D. H., and DePinho, R. A. (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323
27. Zhang, Y., Xing, Y., Zhang, L., Mei, Y., Yamamoto, K., Mak, T. W., and You, H. (2012) Regulation of cell cycle progression by forkhead transcription factor FOXO3 through its binding partner DNA replication factor Cdt1. Proc. Natl. Acad. Sci. U.S.A. 109, 5717-5722
28. Santamaría, C. M., Chillón, M. C., García-Sanz, R., Pérez, C., Caballero, M. D., Ramos, F., de Coca, A. G., Alonso, J. M., Giraldo, P., Bernal, T., Queizán, J. A., Rodriguez, J. N., Fernández-Abellán, P., Bárez, A., Peñarrubia, M. J., Vidriales, M. B., Balanzategui, A., Sarasquete, M. E., Alcoceba, M., Díaz-Mediavilla, J., San Miguel, J. F., and Gonzalez, M. (2009) High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics. Leuk. Res. 33, 1706-1709
29. Naka, K., Hoshii, T., Muraguchi, T., Tadokoro, Y., Ooshio, T., Kondo, Y., Nakao, S., Motoyama, N., and Hirao, A. (2010) TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463, 676-680
30. Sykes, S. M., Lane, S. W., Bullinger, L., Kalaitzidis, D., Yusuf, R., Saez, B., Ferraro, F., Mercier, F., Singh, H., Brumme, K. M., Acharya, S. S., Scholl, C., Schöll, C., Tothova, Z., Attar, E. C., Fröhling, S., DePinho, R. A., Armstrong, S. A., Gilliland, D. G., and Scadden, D. T. (2011) AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 146, 697-708
31. Lei, H., and Quelle, F. W. (2009) FOXO transcription factors enforce cell cycle checkpoints and promote survival of hematopoietic cells after DNA damage. Mol. Cancer Res. 7, 1294-1303
32. Li, Z., Zhang, H., Chen, Y., Fan, L., and Fang, J. (2012) Forkhead transcription factor FOXO3a protein activates nuclear factor κB through B-cell lymphoma/leukemia 10 (BCL10) protein and promotes tumor cell survival in serum deprivation. J. Biol. Chem. 287, 17737-17745
33. Sakamaki, J., Daitoku, H., Kaneko, Y., Hagiwara, A., Ueno, K., and Fukamizu, A. (2012) GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1. J. Recept. Signal. Transduct. Res. 32, 96-101
34. Xuan, Z., and Zhang, M. Q. (2005) From worm to human: bioinformatics approaches to identify FOXO target genes. Mech. Ageing Dev. 126, 209-215
35. Chandarlapaty, S., Sawai, A., Scaltriti, M., Rodrik-Outmezguine, V., Grbovic-Huezo, O., Serra, V., Majumder, P. K., Baselga, J., and Rosen, N. (2011) AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. Cancer Cell 19, 58-71
36. Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A., and Baserga, R. (1993) Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 11217-11221
37. Hellawell, G. O., Turner, G. D., Davies, D. R., Poulsom, R., Brewster, S. F., and Macaulay, V. M. (2002) Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res. 62, 2942-2950
38. Law, J. H., Habibi, G., Hu, K., Masoudi, H., Wang, M. Y., Stratford, A. L., Park, E., Gee, J. M., Finlay, P., Jones, H. E., Nicholson, R. I., Carboni, J., Gottardis, M., Pollak, M., and Dunn, S. E. (2008) Phosphorylated insulinlike growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res. 68, 10238-10246
39. Flossmann-Kast, B. B., Jehle, P. M., Hoeflich, A., Adler, G., and Lutz, M. P. (1998) Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells. Cancer Res. 58, 3551-3554
40. Tanno, S., Tanno, S., Mitsuuchi, Y., Altomare, D. A., Xiao, G. H., and Testa, J. R. (2001) AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res. 61, 589-593
41. Qin, L., Wang, Y., Tao, L., and Wang, Z. (2011) AKT down-regulates insulin-like growth factor-1 receptor as a negative feedback. J. Biochem. 150, 151-156
42. Werner, H., Hernández-Sánchez, C., Karnieli, E., and Leroith, D. (1995) The regulation of IGF-I receptor gene expression. Int. J. Biochem. Cell Biol. 27, 987-994
43. Genua, M., Pandini, G., Sisci, D., Castoria, G., Maggiolini, M., Vigneri, R., and Belfiore, A. (2009) Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells. Cancer Res. 69, 7270-7277
44. Werner, H., Karnieli, E., Rauscher, F. J., and LeRoith, D. (1996) Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. U.S.A. 93, 8318-8323
45. Werner, H., Re, G. G., Drummond, I. A., Sukhatme, V. P., Rauscher, F. J., 3rd, Sens, D. A., Garvin, A. J., LeRoith, D., and Roberts, C. T., Jr. (1993) Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc. Natl. Acad. Sci. U.S.A. 90, 5828-5832
46. Karnieli, E., Werner, H., Rauscher, F. J., 3rd, Benjamin, L. E., and LeRoith, D. (1996) The IGF-I receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein. J. Biol. Chem. 271, 19304-19309
47. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., Wang, C. Y., He, X., MacDougald, O. A., You, M., Williams, B. O., and Guan, K. L. (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955-968
48. Shin, S., Wolgamott, L., Yu, Y., Blenis, J., and Yoon, S. O. (2011) Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 108, E1204-E1213
49. Tang, Q. L., Xie, X. B., Wang, J., Chen, Q., Han, A. J., Zou, C. Y., Yin, J. Q., Liu, D. W., Liang, Y., Zhao, Z. Q., Yong, B. C., Zhang, R. H., Feng, Q. S., Deng, W. G., Zhu, X. F., Zhou, B. P., Zeng, Y. X., Shen, J. N., and Kang, T. (2012) Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma. J. Natl. Cancer Inst. 104, 749-763
50. Vecchione, A., Marchese, A., Henry, P., Rotin, D., and Morrione, A. (2003) The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Mol. Cell. Biol. 23, 3363-3372
51. Fu, Z., and Tindall, D. J. (2008) FOXOs, cancer and regulation of apoptosis. Oncogene 27, 2312-2319
52. Puig, O., and Tjian, R. (2005) Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev. 19, 2435-2446
53. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868
54. Muranen, T., Selfors, L. M., Worster, D. T., Iwanicki, M. P., Song, L., Morales, F. C., Gao, S., Mills, G. B., and Brugge, J. S. (2012) Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. Cancer Cell 21, 227-239